Person entering Gilead building Leading the pack is Gilead Sciences' HIV medication Biktarvy, which had U.S. sales revenue five times greater than the rest of the world. (Photo: David Paul Morris/Bloomberg)

Americans spent nearly twice as much on the 20 top-selling pharmaceuticals as the rest of the world combined last year, according to an analysis by the interest group Public Citizen.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Core and Group Health
Health Care Reform
Employee-Paid
Employer-Paid